Goldman Sachs’s Acadia Healthcare ACHC Stock Holding History

Goldman Sachs’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-44,500	Closed	-$1.57M	–	5191
2018 Q3	$1.57M	Buy	+44,500	New	+$1.77M	﹤0.01%	3753
2017 Q3	–	Sell	-66,400	Closed	-$3.28M	–	6630
2017 Q2	$3.28M	Sell	66,400 -32,500	-33%	-$1.44M	﹤0.01%	3415
2017 Q1	$4.31M	Sell	98,900 -25,500	-20%	-$1.03M	﹤0.01%	3061
2016 Q4	$4.12M	Buy	124,400 +30,200	+32%	+$1.17M	﹤0.01%	3212
2016 Q3	$4.67M	Buy	94,200 +50,000	+113%	+$2.6M	﹤0.01%	3099
2016 Q2	$2.45M	Buy	44,200 +19,200	+77%	+$1.12M	﹤0.01%	3438
2016 Q1	$1.38M	Buy	+25,000	New	+$1.43M	﹤0.01%	3805
2015 Q4	–	Sell	-5,000	Closed	-$331K	–	7113
2015 Q3	$331K	Sell	5,000 -2,500	-33%	-$192K	﹤0.01%	5515
2015 Q2	$587K	Sell	7,500 -19,500	-72%	-$1.4M	﹤0.01%	5018
2015 Q1	$1.93M	Buy	27,000 +2,500	+10%	+$160K	﹤0.01%	3817
2014 Q4	$1.5M	Buy	+24,500	New	+$1.43M	﹤0.01%	4141

Other funds holding ACHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs's ACHC Position: Q1 2026 in Review

Goldman Sachs reduced its Acadia Healthcare (ACHC) stake by 53% in Q1 2026, selling an estimated $45M and leaving 2,240,428 shares worth $52.4M. The position accounts for 0.01% of the portfolio, ranked #1540.

Goldman Sachs first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $216M in Q2 2017. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

Goldman Sachs held 2,240,428 shares of Acadia Healthcare worth $52.4M as of Q1 2026.
Goldman Sachs sold 2,488,185 Acadia Healthcare shares in Q1 2026, an estimated $45M.
Acadia Healthcare made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1540 holding.
Goldman Sachs first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
Goldman Sachs's Acadia Healthcare position peaked at $216M in Q2 2017.
295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.